Tuesday, March 28, 2017 5:47:50 PM
Dear new member,
I sent you a special alert this morning about a very hot biotech company that caught my attention after it announced breaking news last night.
IMMG seems to be on the verge on curing cancer according to its latest press release. It has just completed animal trials with the blessing of the FDA and successfully killed off as many as 31961785 different cancer cells in the subject mice with its non-invasive genetic therapy.
This could change the world and it could put IMMGon the map forever.
In my opinion, a company that can eventually cure cancer with easy-to-apply gene therapies should be worth a hundred dollars a share.
IMMGis just at pennies right now, it’s what I call the basement floor. You should consider buying shares immediately before this elevator climbs higher.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM